| Dr Keith A Boles, MD | |
|
500 South Johnson Drive, Mcgregor, TX 76657 | |
| (254) 313-5200 | |
| (254) 313-4531 |
| Full Name | Dr Keith A Boles |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 500 South Johnson Drive, Mcgregor, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710946561 | NPI | - | NPPES |
| 8B5536 | Other | TX | BLUE SHIELD |
| 1119000-10 | Other | TX | CSHCN |
| 1119000-07 | Medicaid | TX | |
| 080176902 | Other | TX | RR/MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K2852 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Interim Healthcare Of Waco | Woodway, TX | Home health agency |
| Providence Health Center | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heart Of Texas Community Health Center, Inc. | 1153370242 | 95 |
News Archive
Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce a new Dynamic Fielding feature in its GeneSys image capture software.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed in the Orange Book in connection with Fentora® (fentanyl buccal tablets, 100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg).
A newborn rat's brain development stage is close to that of a human embryo in the second half of pregnancy, so this discovery allows to hypothesize that the same movement patterns can help neuron development in humans.
› Verified 4 days ago
| Entity Name | Mclennan County Medical Education And Research Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689651440 PECOS PAC ID: 0042205155 Enrollment ID: O20040419000208 |
News Archive
Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce a new Dynamic Fielding feature in its GeneSys image capture software.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed in the Orange Book in connection with Fentora® (fentanyl buccal tablets, 100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg).
A newborn rat's brain development stage is close to that of a human embryo in the second half of pregnancy, so this discovery allows to hypothesize that the same movement patterns can help neuron development in humans.
› Verified 4 days ago
| Entity Name | Heart Of Texas Community Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568191492 PECOS PAC ID: 1153370242 Enrollment ID: O20050114000813 |
News Archive
Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce a new Dynamic Fielding feature in its GeneSys image capture software.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed in the Orange Book in connection with Fentora® (fentanyl buccal tablets, 100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg).
A newborn rat's brain development stage is close to that of a human embryo in the second half of pregnancy, so this discovery allows to hypothesize that the same movement patterns can help neuron development in humans.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keith A Boles, MD 1600 Providence Dr, Waco, TX 76707-2261 Ph: (254) 313-4200 | Dr Keith A Boles, MD 500 South Johnson Drive, Mcgregor, TX 76657 Ph: (254) 313-5200 |
News Archive
Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).
Syngene, a world-leading manufacturer of image analysis solutions, is pleased to introduce a new Dynamic Fielding feature in its GeneSys image capture software.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed in the Orange Book in connection with Fentora® (fentanyl buccal tablets, 100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg).
A newborn rat's brain development stage is close to that of a human embryo in the second half of pregnancy, so this discovery allows to hypothesize that the same movement patterns can help neuron development in humans.
› Verified 4 days ago
Dr. Kelley M Reynolds, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 South Johnson Drive, Mcgregor, TX 76657 Phone: 254-313-5200 Fax: 254-313-4531 | |
Dr. Jessica Kristin Cook, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 South Johnson Drive, Mcgregor, TX 76657 Phone: 254-313-5200 Fax: 254-313-4531 |